Category: Cost and Quality

Buy and Bust: After Platinum Health Took Control of Noble Sites, All Hospital Workers Were Fired

Two Missouri towns are without operating hospitals after private equity-backed Noble Health left both facilities mired in debt, lawsuits, and federal investigations. The hospitals’ new operator, Platinum Health, agreed to buy them in April for $2 and laid off the last employees in early September.

Centene to Pay $166 Million to Texas in Medicaid Drug Pricing Settlement

Texas is at least the 12th state to settle with St. Louis-based Centene Corp. over allegations that it overcharged Medicaid prescription drug programs.

‘An Arm and a Leg’: The New Cap on Medicare Drug Costs

In this episode, Julie Rovner, chief Washington correspondent for KHN, guides listeners through decades of dealings between Congress and Big Pharma.

Hospitals Divert Primary Care Patients to Health Center ‘Look-Alikes’ to Boost Finances

Medicare and Medicaid pay “look-alike” health centers significantly more than hospitals for treating patients, and converting or creating clinics can help hospitals reduce their expenses.

Organ Transplants Are Up, but the Agency in Charge Is Under Fire

A two-year congressional investigation has identified troubling lapses in the nation’s organ transplant system. Blood types mismatched, diseased organs transplanted anyway, and — most often — organs lost or damaged before they can save a life.

‘An Arm and a Leg’: How to Negotiate for Lower Medical Bills

A nonprofit that trains people to apply for charity care has started teaching others how to negotiate with hospitals and debt collectors to lower the amount they owe.

After Wiping Out $6.7 Billion in Medical Debt, This Nonprofit Is Just Getting Started

Nonprofit RIP Medical Debt buys up unpaid hospital bills plaguing low-income patients and frees them from having to pay.

No, the Senate-Passed Reconciliation Bill Won’t Strip $300 Billion From Medicare

Under the Medicare drug negotiations provisions in the reconciliation bill, the federal government would see its outlays reduced by about $300 billion. That reduction wouldn’t result from cuts in benefits. Instead, Medicare would be empowered to leverage its market power to pay lower prices for certain drugs.

Rapper Fat Joe Says No One Is Making Sure Hospitals Post Their Prices

A TV and social media ad offers a reason to check on the enforcement of a sweeping rule that requires hospitals to post information about what they charge insurers and cash-paying patients.

‘An Arm and a Leg’: Her Bill for a Prenatal Test Felt Like a ‘Bait-and-Switch’ Scheme

Her doctor told her the noninvasive genetic test would be $99. When she called, she was told $250 and if she didn’t pay quickly it could be $800.